Adverse effects of iodine thyroid blocking: a systematic review

Spallek L, Krille L, Reiners C, Schneider R, Yamashita S, Zeeb H (2012)
Radiation protection dosimetry 150(3): 267-277.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Spallek, LenaUniBi; Krille, L; Reiners, C; Schneider, R; Yamashita, S; Zeeb, H
Abstract / Bemerkung
(131)I, when released in a radiological or nuclear accident as happened recently in Fukushima, Japan, may cause thyroid cancer as a long-term consequence. Iodine thyroid blocking (ITB) is known to reduce the risk of developing thyroid cancer. Potential adverse effects of ITB have not been systematically investigated so far. This article summarises the results of a review on adverse effects of ITB based on a systematic literature search in scientific medical databases. A meta-analysis was not performed as identified studies displayed major heterogeneity. The search resulted in 14 articles relevant to the topic, reporting mostly on surveys, ecological and intervention studies. Only one study from Poland focused on effects (both desired and adverse) of an ITB intervention following the Chernobyl accident. All other studies reported on iodine administration in a different context. Overall, the studies did not reveal severe adverse reactions to potassium iodide in the general public. Since ITB is a protective measure only applied in very specific circumstances, scientifically sound studies of adverse effects are scarce and consequently the evidence base is weak. The assessment of adverse effects of ITB relies on indirect evidence from related areas. This study may contribute to ongoing developments in pharmacoepidemiology aiming to better quantify adverse effects of medications and health care interventions including ITB.
Thyroid Neoplasms/drug therapy; Thyroid Diseases/chemically induced; Review Literature as Topic; Potassium Iodide/adverse effects; Case-Control Studies; Humans
Radiation protection dosimetry
Page URI


Spallek L, Krille L, Reiners C, Schneider R, Yamashita S, Zeeb H. Adverse effects of iodine thyroid blocking: a systematic review. Radiation protection dosimetry. 2012;150(3):267-277.
Spallek, L., Krille, L., Reiners, C., Schneider, R., Yamashita, S., & Zeeb, H. (2012). Adverse effects of iodine thyroid blocking: a systematic review. Radiation protection dosimetry, 150(3), 267-277. doi:10.1093/rpd/ncr400
Spallek, L., Krille, L., Reiners, C., Schneider, R., Yamashita, S., and Zeeb, H. (2012). Adverse effects of iodine thyroid blocking: a systematic review. Radiation protection dosimetry 150, 267-277.
Spallek, L., et al., 2012. Adverse effects of iodine thyroid blocking: a systematic review. Radiation protection dosimetry, 150(3), p 267-277.
L. Spallek, et al., “Adverse effects of iodine thyroid blocking: a systematic review”, Radiation protection dosimetry, vol. 150, 2012, pp. 267-277.
Spallek, L., Krille, L., Reiners, C., Schneider, R., Yamashita, S., Zeeb, H.: Adverse effects of iodine thyroid blocking: a systematic review. Radiation protection dosimetry. 150, 267-277 (2012).
Spallek, Lena, Krille, L, Reiners, C, Schneider, R, Yamashita, S, and Zeeb, H. “Adverse effects of iodine thyroid blocking: a systematic review”. Radiation protection dosimetry 150.3 (2012): 267-277.

9 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Optimal KI Prophylactic Dose Determination for Thyroid Radiation Protection After a Single Administration in Adult Rats.
Phan G, Rebière F, Suhard D, Legrand A, Carpentier F, Sontag T, Souidi M, Jourdain JR, Agarande M, Renaud-Salis V., Dose Response 15(4), 2017
PMID: 29276472
The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid Blocking.
Reiners C, Schneider R, Akashi M, Akl EA, Jourdain JR, Li C, Murith C, Van Bladel L, Yamashita S, Zeeb H, Vitti P, Carr Z., Radiat Prot Dosimetry 171(1), 2016
PMID: 27664997
The hypothalamic-pituitary-thyroid axis in infants and children: protection from radioiodines.
Fisher J, Yang X, Harris C, Koturbash I, Lumen A., J Thyroid Res 2014(), 2014
PMID: 24971190
Risk of thyroid cancer after the Fukushima nuclear power plant accident.
Yamashita S, Suzuki S., Respir Investig 51(3), 2013
PMID: 23978638

42 References

Daten bereitgestellt von Europe PubMed Central.

Thyroid cancer after Chernobyl.
Kazakov VS, Demidchik EP, Astakhova LN., Nature 359(6390), 1992
PMID: 1522879
Childhood thyroid cancer since accident at Chernobyl.
Stsjazhko VA, Tsyb AF, Tronko ND, Souchkevitch G, Baverstock KF., BMJ 310(6982), 1995
PMID: 7711589
Thyroid cancer in the Ukraine.
Likhtarev IA, Sobolev BG, Kairo IA, Tronko ND, Bogdanova TI, Oleinic VA, Epshtein EV, Beral V., Nature 375(6530), 1995
PMID: 7760928
Chernobyl-related thyroid cancer in children of Belarus: a case-control study.
Astakhova LN, Anspaugh LR, Beebe GW, Bouville A, Drozdovitch VV, Garber V, Gavrilin YI, Khrouch VT, Kuvshinnikov AV, Kuzmenkov YN, Minenko VP, Moschik KV, Nalivko AS, Robbins J, Shemiakina EV, Shinkarev S, Tochitskaya SI, Waclawiw MA., Radiat. Res. 150(3), 1998
PMID: 9728663
Thyroid cancer risk to children calculated.
Jacob P, Goulko G, Heidenreich WF, Likhtarev I, Kairo I, Tronko ND, Bogdanova TI, Kenigsberg J, Buglova E, Drozdovitch V, Golovneva A, Demidchik EP, Balonov M, Zvonova I, Beral V., Nature 392(6671), 1998
PMID: 9510245
Time trends of thyroid cancer incidence in Belarus after the Chernobyl accident.
Heidenreich WF, Kenigsberg J, Jacob P, Buglova E, Goulko G, Paretzke HG, Demidchik EP, Golovneva A., Radiat. Res. 151(5), 1999
PMID: 10319735
Distributing KI pills to minimize thyroid radiation exposure in case of a nuclear accident in France.
Le Guen B, Stricker L, Schlumberger M., Nat Clin Pract Endocrinol Metab 3(9), 2007
PMID: 17710083
Age-dependent potassium iodide effect on the thyroid irradiation by 131I and 133I in the nuclear emergency.
Jang M, Kim HK, Choi CW, Kang CS., Radiat Prot Dosimetry 130(4), 2008
PMID: 18337292
Epidemiology of thyroid diseases in iodine sufficiency.
Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I., Thyroid 8(12), 1998
PMID: 9920375
Iodine supplementation in Austria: methods and results.
Lind P, Kumnig G, Heinisch M, Igerc I, Mikosch P, Gallowitsch HJ, Kresnik E, Gomez I, Unterweger O, Aigner H., Thyroid 12(10), 2002
PMID: 12487773
Potassium iodide sensitivity in four patients with hypocomplementemic vasculitis.
Curd JG, Milgrom H, Stevenson DD, Mathison DA, Vaughan JH., Ann. Intern. Med. 91(6), 1979
PMID: 517884
The Wolff-Chaikoff effect: hypothyroidism due to potassium iodide.
Johnson TM, Rapini RP., Arch Dermatol 124(8), 1988
PMID: 3401021
The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association.
Becker DV, Braverman LE, Dunn JT, Gaitan E, Gorman C, Maxon H, Schneider AB, Van Middlesworth L, Wolff J., JAMA 252(5), 1984
PMID: 6737670
Risks in mass distribution of potassium iodide.
Yalow RS., Bull N Y Acad Med 59(10), 1983
PMID: 6582963
Delayed adverse reactions to iodinated contrast media and their risk factors.
Hosoya T, Yamaguchi K, Akutsu T, Mitsuhashi Y, Kondo S, Sugai Y, Adachi M., Radiat Med 18(1), 2000
PMID: 10852654
Thyroid blockade during a radiation emergency in iodine-rich areas: effect of a stable-iodine dosage.
Takamura N, Nakamura Y, Ishigaki K, Ishigaki J, Mine M, Aoyagi K, Yamashita S., J. Radiat. Res. 45(2), 2004
PMID: 15304961
Radioiodine and thyroid carcinoma: KI prophylaxis in children.
Giovannelli G., Acta Biomed 75(2), 2004
PMID: 15481705
Increased incidence of thyrotoxicosis after iodine supplementation in an iodine sufficient area.
Galofre JC, Fernandez-Calvet L, Rios M, Garcia-Mayor RV., J. Endocrinol. Invest. 17(1), 1994
PMID: 8006325
Endemic goitre in central China caused by excessive iodine intake.
Li M, Liu DR, Qu CY, Zhang PY, Qian QD, Zhang CD, Jia QZ, Wang HX, Eastman CJ, Boyages SC., Lancet 2(8553), 1987
PMID: 2886725
Evolution of thyroid autoimmunity during iodine prophylaxis--the Sri Lankan experience.
Mazziotti G, Premawardhana LD, Parkes AB, Adams H, Smyth PP, Smith DF, Kaluarachi WN, Wijeyaratne CN, Jayasinghe A, de Silva DG, Lazarus JH., Eur. J. Endocrinol. 149(2), 2003
PMID: 12887286
Thyroid function changes related to use of iodinated water in the U.S. Space Program.
McMonigal KA, Braverman LE, Dunn JT, Stanbury JB, Wear ML, Hamm PB, Sauer RL, Billica RD, Pool SL., Aviat Space Environ Med 71(11), 2000
PMID: 11086666
Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment.
Minelli R, Braverman LE, Giuberti T, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Roti E., Clin. Endocrinol. (Oxf) 47(3), 1997
PMID: 9373459
Urinary iodine and thyroid antibodies in Okinawa, Yamagata, Hyogo, and Nagano, Japan: the differences in iodine intake do not affect thyroid antibody positivity.
Nagata K, Takasu N, Akamine H, Ohshiro C, Komiya I, Murakami K, Suzawa A, Nomura T., Endocr. J. 45(6), 1998
PMID: 10395237
The effect of small increases in dietary iodine on thyroid function in euthyroid subjects.
Paul T, Meyers B, Witorsch RJ, Pino S, Chipkin S, Ingbar SH, Braverman LE., Metab. Clin. Exp. 37(2), 1988
PMID: 3340004
Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE., J. Clin. Endocrinol. Metab. 76(4), 1993
PMID: 7682562
High thyroid volume in children with excess dietary iodine intakes.
Zimmermann MB, Ito Y, Hess SY, Fujieda K, Molinari L., Am. J. Clin. Nutr. 81(4), 2005
PMID: 15817861
Thyroid blocking policy--revisited.
Solanki KK, Bomanji JB, Waddington WA, Ell PJ; UK Administration of Radioactive Substances Advisory Committee., Nucl Med Commun 25(11), 2004
PMID: 15577583


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 22021061
PubMed | Europe PMC

Suchen in

Google Scholar